<- Go Home
cbdMD, Inc.
cbdMD, Inc. produces and distributes various cannabidiol (CBD) products in the United States and internationally. The company owns and operates various consumer hemp-based CBD brands. Its cbdMD brand products include oils, gummies, capsules, soft-gels, topicals, functional formulations, and hemp-derived compliant Delta-9 THC products. It also provides products for dogs and cats, including tinctures, chews, and topicals under the Paw CBD brand name; non-cannabinoid functional ingredients, such as functional mushrooms under the ATRx brand; and hemp-derived solutions under the Herbal Oasis brand. It serves retailers, and health and pet channels through the direct-to-consumer channel, e-commerce platforms, online marketplaces, and wholesale distribution. The company was formerly known as Level Brands, Inc. and changed its name to cbdMD, Inc. in May 2019. cbdMD, Inc. is based in Charlotte, North Carolina.
Market Cap
$7.4M
Volume
949.0K
Cash and Equivalents
$2.3M
EBITDA
-$1.0M
Tax Rate Collected
N/A
Tax Rate Ratio
N/A
Gross Profit
$12.0M
Profit Margin
62.37%
52 Week High
$4.50
52 Week Low
$0.47
Dividend
N/A
Price / Book Value
0.87
Price / Earnings
-0.64
Price / Tangible Book Value
1.23
Enterprise Value
$5.9M
Enterprise Value / EBITDA
16.69
Operating Income
-$2.2M
Return on Equity
44.42%
Return on Assets
-12.87
Cash and Short Term Investments
$2.3M
Debt
$778.2K
Equity
$7.2M
Revenue
$19.2M
Unlevered FCF
-$4.9M
Sector
Pharmaceuticals
Category
N/A
Hedge Funds that own this stock
PREMIUM
Upgrade to Yellowbrick Premium to unlock the Professional Funds that own this company (and many other perks).
Upgrade to Yellowbrick PremiumYellowbrick Portfolios that own this stock
PREMIUM
Upgrade to Yellowbrick Premium to unlock the Yellowbrick portfolios that own this company (and many other perks).
Upgrade to Yellowbrick Premium